Biological Intellectual Property Protection Act of 2025
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill states concern about Chinese exploitation of United States biological and synthetic biology intellectual property and requires export licenses for certain human- or AI-designed synthetic DNA or RNA sequences transferred to foreign entities of concern.
Who Benefits and How
United States biological intellectual property and sensitive synthetic biology information could receive stronger export controls aimed at foreign entities of concern.
Who Bears the Burden and How
United States synthetic biology exporters would face new licensing requirements before exporting covered digital sequence information to foreign entities of concern.
Key Provisions
- States congressional concern about Chinese access to sensitive United States data and intellectual property.
- Creates a new export license requirement for certain synthetic biology-related digital sequence transfers to foreign entities of concern.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
This bill states concern about Chinese exploitation of United States biological and synthetic biology intellectual property and requires export licenses for certain human- or AI-designed synthetic DNA or RNA sequences transferred to foreign entities of concern.
Key Policy Areas
National Security, Technology
Primary Purpose
This bill states concern about Chinese exploitation of United States biological and synthetic biology intellectual property and requires export licenses for certain human- or AI-designed synthetic DNA or RNA sequences transferred to foreign entities of concern.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- United States synthetic biology intellectual property and security interests
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- United States exporters of covered synthetic DNA or RNA sequence information
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeRead twice and referred to the Committee on Banking, Housing, …
Introduced in Senate
Mr. Cotton (for himself, Ms. Hassan, and Mr. Budd) introduced …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
United States exporters of covered synthetic DNA or RNA sequence information
Foreign entities of concern seeking access to covered synthetic biology sequence information
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology